Roche and GE Healthcare Launch NAVIFY Tumor Board 2.0 for Personalized Treatment Decision in Cancer Care
Shots:
- The NAVIFY Tumor Board 2.0 with medical imaging capabilities brings a personalized treatment in patients with cancer with its initial availability in the US & Canada
- The tumor board enables radiologists to upload their patient records to the same dashboard where the patient’s previous treatment details are stored- helping the clinicians to have a quick review of all relevant files and to choose the best treatment for each cancer patient
- The NAVIFY tumor board is a web-based cancer care team workflow tool- presenting data in a dashboard and standardizes processes to encourage collaboration on patient treatment decisions
Ref: Roche | Image: Roche
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com